We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
-1.05%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
AUM
$750M
AUM Growth
+$15.2M
Cap. Flow
+$28.5M
Cap. Flow %
3.81%
Top 10 Hldgs %
32.25%
Holding
203
New
12
Increased
82
Reduced
87
Closed
19

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$19.1M
2
AMZN icon
Amazon
AMZN
+$5.56M
3
V icon
Visa
V
+$4.69M
4
DIS icon
Walt Disney
DIS
+$4.56M
5
VFC icon
VF Corp
VFC
+$3.31M

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Healthcare 12.08%
3 Financials 10.9%
4 Consumer Staples 9.98%
5 Communication Services 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKTA icon
126
Okta
OKTA
$24.7B
$397K 0.05%
1,673
-7
-0.4% -$1.74K
TWLO icon
127
Twilio
TWLO
$30B
$397K 0.05%
1,244
+75
+6% +$27.3K
CALY
128
Callaway Golf Company
CALY
$3.32B
$394K 0.05%
+14,264
New +$434K
NBIX icon
129
Neurocrine Biosciences
NBIX
$16.8B
$381K 0.05%
3,972
-28
-0.7% -$2.65K
IWB icon
130
iShares Russell 1000 ETF
IWB
$48.2B
$379K 0.05%
+1,566
New +$389K
ALRM icon
131
Alarm.com
ALRM
$2.71B
$366K 0.05%
4,678
-19
-0.4% -$1.57K
GH icon
132
Guardant Health
GH
$21.7B
$364K 0.05%
2,912
-13
-0.4% -$1.54K
TWOU
133
DELISTED
2U Inc
TWOU
$361K 0.05%
358
-2
-0.6% -$2.34K
VRTX icon
134
Vertex Pharmaceuticals
VRTX
$121B
$359K 0.05%
1,981
+2
+0.1% +$390
MED icon
135
Medifast
MED
$109M
$356K 0.05%
1,849
-10
-0.5% -$2.46K
SHV icon
136
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$356K 0.05%
3,226
-362
-10% -$40K
APPF icon
137
AppFolio
APPF
$6.38B
$355K 0.05%
2,952
-20
-0.7% -$2.6K
ROKU icon
138
Roku
ROKU
$21.5B
$351K 0.05%
1,120
-4
-0.4% -$1.51K
CDNA icon
139
CareDx
CDNA
$2.26B
$345K 0.05%
5,445
-11
-0.2% -$838
SAIL
140
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$343K 0.05%
7,992
-46
-0.6% -$2.18K
YEXT icon
141
Yext
YEXT
$547M
$337K 0.04%
27,987
-206
-0.7% -$2.65K
CORT icon
142
Corcept Therapeutics
CORT
$12.4B
$327K 0.04%
16,600
-92
-0.6% -$1.93K
MDY icon
143
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$323K 0.04%
+672
New +$330K
QTRX icon
144
Quanterix
QTRX
$164M
$320K 0.04%
6,431
-33
-0.5% -$1.7K
FOLD
145
DELISTED
Amicus Therapeutics
FOLD
$319K 0.04%
33,391
+1,699
+5% +$17.4K
RARE icon
146
Ultragenyx Pharmaceutical
RARE
$2.45B
$318K 0.04%
3,521
+203
+6% +$18.3K
EDIT icon
147
Editas Medicine
EDIT
$396M
$317K 0.04%
7,715
-334
-4% -$18.3K
ZM icon
148
Zoom
ZM
$28.2B
$313K 0.04%
1,197
-7
-0.6% -$2.36K
TWST icon
149
Twist Bioscience
TWST
$5.7B
$310K 0.04%
2,898
-22
-0.8% -$2.52K
BEAM icon
150
Beam Therapeutics
BEAM
$2.63B
$309K 0.04%
3,552
-160
-4% -$16.1K

Similar funds

Spearhead Capital Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Spearhead Capital Advisors held 203 positions worth $750M, up 2.1% from $735M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Spearhead Capital Advisors deployed $28.5M of net new capital in Q3 2021, opening 12 new positions and adding to 82 existing holdings. Its largest new stake was Realty Income: 283,375 shares worth $17.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Costco, an estimated $1.5M trimmed.

  • Spearhead Capital Advisors's largest Q3 2021 buy was Realty Income: 283,375 shares worth $17.8M.
  • Spearhead Capital Advisors added most to Amazon in Q3 2021, an estimated $5.56M increase.
  • Spearhead Capital Advisors's biggest Q3 2021 reduction was Costco, cutting an estimated $1.5M.
  • Spearhead Capital Advisors fully exited Emerson Electric in Q3 2021, selling an estimated $9.31M.
  • Spearhead Capital Advisors's ten largest holdings make up 32% of its $750M portfolio in Q3 2021.
  • Spearhead Capital Advisors opened 12 new positions and closed 19 in Q3 2021.
  • Spearhead Capital Advisors's portfolio value rose 2.1% quarter-over-quarter to $750M.

Based on Spearhead Capital Advisors's 13F filing for Q3 2021, filed 27 Oct 2021.